NCT05119946

Brief Summary

This initial study is a pilot feasibility study with a primary objective of assessing the feasibility of a larger study by evaluating the procedures and methodology, as well as collecting pilot data. The eventual research goal is to demonstrate whether a suicide prevention video in addition to standard care for suicidality is an effective strategy to reduce suicidal behaviours in individuals with a history of such. The suicide prevention video is developed as an educational tool to inform participants of the various consequences of suicide as well as giving a message of hope. It is hoped that such an approach will help to reduce future suicidal behaviours in those who have a history of such. If so, then this could be made as a part of the standard of care in treating patients with suicidality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

November 15, 2021

Completed
Last Updated

November 15, 2021

Status Verified

November 1, 2021

Enrollment Period

3.4 years

First QC Date

August 23, 2016

Last Update Submit

November 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • An assessment of suicidal behaviours following the use of a video intervention

    To assess the change in suicidality of patients admitted for such using the Modified Scale for Suicidal Ideation after being given an educational video explaining common misinformation about suicide.

    12 months

Secondary Outcomes (1)

  • Mean change from baseline in the expression of suicidal ideation on the Modified Scale for Suicidal Ideation at 48 hours, 3 months and 6 months

    12 months

Study Arms (2)

Suicide prevention video

EXPERIMENTAL

In this group, in addition to receiving the standard of care for their suicidality, the participants will also view a suicide prevention video.

Behavioral: Suicide prevention videoOther: Standard suicide treatment

Standard suicide treatment

ACTIVE COMPARATOR

In this group, participants will only receive the standard of care for their suicidality, which can include medications and/or therapy. The care will be determine by their attending physician.

Other: Standard suicide treatment

Interventions

The video has been developed by the research team as an educational tool to teach patients about suicide, the consequences of such and imparting a message of hope.

Suicide prevention video

The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy

Standard suicide treatmentSuicide prevention video

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 19 years or older
  • Admitted to the Royal Columbian Hospital under psychiatric services
  • Individuals will have had suicidal behaviours as part of their presentation leading to hospitalization
  • Individuals must be at the level 2 observation privileges or higher
  • Individuals must be capable of giving consent to participate in the study
  • Individuals must speak and read English fluently Individuals admitted to the hospital as voluntary and involuntary (certified) patients

You may not qualify if:

  • Individuals with hearing or visual deficits that impairs hearing or viewing the SPV
  • Individuals who are under the influence of drugs, such as intoxication or active withdrawal
  • Individuals with established diagnoses of cognitive impairment affecting their ability to give consent, understand what is expected of them in the study or follow directions
  • Patients that require a substitute decision makers to provide consent
  • Individuals whose behaviors an/or cognition are actively affected by ongoing psychosis, including hallucinations, delusions, and disorganized behaviors
  • Individuals whose treating team assess them as likely to have a negative response to the SPV, for example paranoia around electronic devices
  • Patient's who's attending physiatrist is one of the study team members
  • Patients who are currently under the direct care of any of the investigators Patients that had acute suicidality in the last 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Columbian and Eagle Ridge Hospitals

New Westminster, British Columbia, Canada

Location

MeSH Terms

Conditions

Suicidal IdeationSuicide, AttemptedMental Disorders

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Hem Phaterpekar, MD

    Fraser Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2016

First Posted

November 15, 2021

Study Start

January 1, 2017

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

November 15, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations